A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging

Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...

Description complète

Détails bibliographiques
Auteurs principaux:	Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N
Format:	Journal article
Publié:	Wiley 2018

Documents similaires

No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
par: Andrea Hartner, et autres
Publié: (2023-06-01)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
par: Chan, M, et autres
Publié: (2016)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
par: Yeh, TL, et autres
Publié: (2017)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
par: McNeill, L, et autres
Publié: (2002)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
par: Mole, D, et autres
Publié: (2003)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
par: Cockman, M, et autres
Publié: (2019)

Regulation of HIF: prolyl hydroxylases.
par: Stolze, I, et autres
Publié: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
par: Chowdhury, R, et autres
Publié: (2016)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
par: Schlemminger, I, et autres
Publié: (2003)

Inhibition of a viral prolyl hydroxylase
par: Langley, G, et autres
Publié: (2019)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
par: Chowdhury, R, et autres
Publié: (2013)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
par: Matthew E Cockman, et autres
Publié: (2019-09-01)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
par: Holt-Martyn, JP, et autres
Publié: (2019)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
par: Lippl, K, et autres
Publié: (2015)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
par: Rasheduzzaman Chowdhury, et autres
Publié: (2016-08-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
par: Tuckerman, JR, et autres
Publié: (2004)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
par: Willam, C, et autres
Publié: (2006)

Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding
par: Thinnes, C, et autres
Publié: (2018)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
par: Chen, R, et autres
Publié: (2014)

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
par: Chen, R, et autres
Publié: (2014)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
par: Flashman, E, et autres
Publié: (2010)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
par: Moritz J. Strowitzki, et autres
Publié: (2021-04-01)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
par: Astuti, D, et autres
Publié: (2010)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
par: Masson, N, et autres
Publié: (2003)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
par: Holt-Martyn, J, et autres
Publié: (2019)

The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin.
par: Masson, N, et autres
Publié: (2004)

Prolyl hydroxylases and therapeutics.
par: Smith, T, et autres
Publié: (2010)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
par: Wijeyekoon, JB
Publié: (2013)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
par: Maria Savyuk, et autres
Publié: (2020-07-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
par: Andrey A. Poloznikov, et autres
Publié: (2021-01-01)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
par: Singh, A, et autres
Publié: (2020)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
par: Yeoh, K, et autres
Publié: (2013)

Oxygen sensing by HIF hydroxylases.
par: Schofield, C, et autres
Publié: (2004)

Signalling hypoxia by HIF hydroxylases.
par: Schofield, C, et autres
Publié: (2005)

Studies on the substrate selectivity of the hypoxia-inducible factor prolyl hydroxylase 2 catalytic domain
par: Abboud, M, et autres
Publié: (2018)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
par: Richardson, NL, et autres
Publié: (2021)

Therapeutic manipulation of the HIF hydroxylases.
par: Nagel, S, et autres
Publié: (2010)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
par: Mecinovic, J, et autres
Publié: (2007)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
par: Lippl, K
Publié: (2018)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
par: Takahiro Kambara, et autres
Publié: (2024-03-01)